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Abstract
Background: There are limited data describing gender differences in patients
undergoing chronic total occlusion (CTO) percutaneous coronary interventions (PCI).
Methods: We compared baseline clinical and angiographic characteristics and
procedural outcomes between men and women among 9457 CTO PCIs performed
at 38 centers between 2012 and 2022.
Results: A total of 7687 (81%) men and 1770 (19%) women were treated. Women
were older, more likely to have comorbidities such as diabetes, hypertension and
peripheral arterial disease, and had higher left ventricular ejection fraction. The most
common CTO target vessel was the right coronary artery for both men (53%) and
women (52%), although the left anterior descending artery was more frequently the
target vessel among women (31% vs. 25%; p < 0.001). The J‐CTO score (2.4 ± 1.3 vs.
2.2 ± 1.2; p < 0.001) as well as the PROGRESS‐CTO score (1.3 ± 1.0 vs. 1.1 ± 1.0;
p < 0.001) were higher among men. In female patients, antegrade wiring was more
frequently the initial crossing strategy (87.6% vs. 82.4%; p < 0.001) and was more
successful in crossing the target lesion (62.7% vs. 54.0%; p < 0.001) compared with
men. Interventions in men required longer procedure time and fluoroscopy time, as
well as higher air kerma radiation dose and contrast volume when compared to
women. Technical (89% vs. 86%; p < 0.001) and procedural (87% vs. 84%; p = 0.003)
success rates were higher among women. In‐hospital major adverse cardiovascular
events (MACE) were also higher in women (2.9% vs. 1.8%; p < 0.001).
Conclusions: Women undergoing CTO PCI had higher technical and procedural
success rates, but also higher in‐hospital MACE compared with men.
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| INTRODUCTION

Technical

success

was

defined

as
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successful

CTO

revascularization with achievement of <30% residual diameter
Women are underrepresented in chronic total occlusion (CTO)

stenosis within the treated segment and restoration of TIMI grade

percutaneous coronary intervention (PCI) registries and clinical

3 antegrade flow. Procedural success was defined as the achieve-

trials.1,2 Sex‐related differences in clinical outcomes in patients with

ment of technical success without any in‐hospital major adverse

CTOs undergoing revascularization are not well described, as CTO

cardiac events (MACE). In‐hospital MACE included any of the

revascularization is relatively infrequent in female patients.

3,4

The

following adverse events before hospital discharge: death, MI,

impact of sex‐differences on the outcomes of patients undergoing

recurrent

CTO PCI continues to be elusive, and was the focus of the present

revascularization with PCI or coronary artery bypass graft (CABG)

symptoms

requiring

urgent

repeat

target‐vessel

study.

2
2.1

| MATERIALS AND METHODS
| Patient population

TABLE 1
by gender

Clinical characteristics of the study patients stratified

Variables
Age, yrs
2

Male
(n = 7687)

Female
(n = 1770)

p Value

64.1 ± 10.2

65.8 ± 10.5

<0.001

We analyzed the baseline clinical and angiographic characteristics

BMI, kg/m

30.2 ± 5.6

31.2 ± 7.3

<0.001

and procedural outcomes of 9457 CTO PCIs performed between

Diabetes mellitus

41.2%

48.8%

<0.001

Hypertension

88.9%

92.1%

<0.001

dedicated online database (PROGRESS CTO: Prospective Global

Dyslipidemia

86.6%

86.5%

0.939

Registry for the Study of Chronic Total Occlusion Intervention;

Smoking, current

25.5%

21.9%

0.002

Clinicaltrials.gov identifier: NCT02061436). Study data were col-

Left ventricular EF, %

53 (41,60)

55 (45,60)

Family history of CAD

31.8%

32.6%

0.597

Congestive heart
failure

28.9%

28.1%

0.512

Prior myocardial
infarction

46.3%

40.6%

<0.001

Prior PCI

62.9%

56.1%

<0.001

Prior CABG

30.5%

23.4%

<0.001

Cerebrovascular
disease

9.9%

11.3%

0.072

Peripheral arterial
disease

13.7%

16.6%

0.002

Chronic lung disease

13.5%

19.2%

0.163

2012 and 2022 at 38 centers. Patients who had a second CTO lesion
were excluded from the analysis. Data collection was recorded in a

lected and managed using REDCap (Research Electronic Data
Capture) electronic data capture tools hosted at the Minneapolis
Heart Institute Foundation.5,6 The study was approved by the
institutional review board of each center.

2.2

| Definitions

Coronary CTOs were defined as coronary lesions with TIMI
(Thrombolysis in Myocardial Infarction) Grade 0 flow of at least 3
months in duration. Estimation of the duration of occlusion was
clinical, based on the first onset of angina, prior history of myocardial
infarction (MI) in the target vessel territory, or comparison with a
prior angiogram. Calcification was assessed by angiography as mild
(spots), moderate (involving ≤ 50% of the reference lesion diameter),

CAD presentation

or severe (involving > 50% of the reference lesion diameter).

Stable angina

67.8%

65.2%

Moderate proximal vessel tortuosity was defined as the presence

Unstable angina

14.5%

16.4%

NSTEMI

7.3%

10.1%

was defined as lack of tapering or lack of a funnel shape at the

STEMI

1.4%

1.3%

proximal cap. Interventional collateral vessels were defined as

Nonischemic
symptoms

2.5%

2.1%

collateral vessels considered amenable to crossing by a guidewire
and a microcatheter by the operator. A procedure was defined as

No symptoms

6.5%

4.9%

retrograde if an attempt was made to cross the lesion through a
collateral vessel or bypass graft supplying the target vessel distal to

Baseline creatinine
(mg/dl)

1.03
(0.91, 1.21)

0.90
(0.75, 1.10)

the lesion. Antegrade dissection/re‐entry was defined as antegrade

Currently on dialysis

2.3%

3.2%

of at least 2 bends >70° or 1 bend >90° and severe tortuosity as 2
bends >90° or 1 bend >120° in the CTO vessel. Blunt or no stump

<0.001

<0.001

<0.001

0.026

PCI during which a guidewire was intentionally introduced into the
extraplaque space proximal or within occlusion, or re‐entry into the
distal true lumen was attempted after intentional or inadvertent
extraplaque guidewire crossing.

Abbreviations: BMI, body mass index; CABG, coronary artery bypass graft;
CAD, coronary artery disease; EF, ejection fraction; NSTEMI, non‐ST
segment elevation myocardial infarction; PCI, percutaneous coronary
intervention; STEMI, ST‐segment elevation myocardial infarction.
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surgery, tamponade requiring either pericardiocentesis or surgery,

as mean ± standard deviation or as median (interquartile range [IQR])

and stroke. MI was defined using the Third Universal Definition of

unless otherwise specified and were compared using Student's t test

Myocardial Infarction (type 4a MI).7 The Japanese CTO (J‐CTO) score

for normally distributed variables and the Wilcoxon rank‐sum test for

was calculated as described by Morino et al.,8 the PROGRESS‐CTO

nonparametric variables, as appropriate. The variables associated

score as described by Christopoulos et al.9 and the PROGRESS‐CTO

with technical success and MACE were examined using univariable

complications score as described by Danek et al.10

logistic regression; variables that had p < 0.10 and were deemed

2.3

| Statistical analysis

TABLE 3
by gender

Technical characteristics of the study lesions stratified

Categorical variables were expressed as percentages and compared

Male
(n = 7687)

Female
(n = 1770)

Right femoral

70.8%

73.6%

0.019

Left femoral

35.9%

38.5%

0.037

p Value

Right radial

48.4%

43.2%

<0.001

<0.001

Left radial

18.2%

15.7%

0.012

using Pearson's chi‐square test. Continuous variables are presented

Variables

p Value

Access site

T A B L E 2 Angiographic characteristics of the study lesions
stratified by gender
Variables

Male
(n = 7687)

Female
(n = 1770)

CTO target vessel
RCA

52.9%

52.1%

Bifemoral approach

33.1%

35.5%

0.049

LAD

25.1%

31.2%

Biradial approach

13.6%

11.2%

0.008

LCX

19.9%

15.1%

Femoral‐radial
approach

28.6%

26.4%

0.066

SVG

0.1%

0%

Left main

0.5%

0.6%

Other

1.6%

1.0%

Antegrade wiring

86.1%

88.7%

0.003

Lesion length, mm

25 (15,40)

23 (15,35)

<0.001

Retrograde

31.7%

26.5%

<0.001

Vessel diameter, mm

2.89 ± 0.50

2.79 ± 0.50

<0.001

22.7%

16.3%

<0.001

Proximal cap ambiguity

35.7%

30.7%

<0.001

Antegrade
dissection and
re‐entry

Side branch at the
proximal cap

55.6%

50.9%

<0.001

Blunt/no stump, %

50.1%

45.4%

<0.001

Moderate/severe
calcification

45.9%

44.7%

0.399

Moderate/severe
proximal tortuosity

30.4%

25.9%

<0.001

Distal cap at
bifurcation

34.0%

31.4%

0.049

Adequate distal
landing zone

66.9%

67.7%

0.547

In‐stent restenosis

16.5%

16.4%

0.867

Prior attempt to
open CTO

19.1%

18.3%

0.437

J‐CTO score

2.41 ± 1.28

2.20 ± 1.23

<0.001

Progress CTO score

1.30 ± 1.02

1.12 ± 0.99

<0.001

Progress CTO
complication score

2.79 ± 1.95

2.82 ± 1.84

0.573

Crossing
strategies used

Initial crossing
strategy
Antegrade wiring

82.4%

87.6%

Retrograde

12.7%

10.0%

4.7%

2.4%

“Interventional”
collaterals

55.9%

60.3%

0.002

Balloon uncrossable
lesions

10.4%

8.3%

0.015

Balloon undilatable
lesions

8.7%

9.1%

0.805

44.7%

48.6%

0.007

Antegrade
dissection and
re‐entry

IVUS use

Abbreviations: CTO, chronic total occlusion; J, Japan; LAD, left anterior
descending artery; LCX, left circumflex artery; PROGRESS, Progressive
Global Registry of Chronic Total Occlusion Interventions; RCA, right
coronary artery; SVG, saphenous vein graft.

<0.001

Number of
stents used

2.33 ± 1.11

2.22 ± 1.04

<0.001

LV assist device used

4.3%

3.4%

0.133

Prophylactic use

2.8%

2.2%

0.141

Urgent use

0.7%

0.8%

0.737

Abbreviations: IVUS, intravascular ultrasound; LIMA, left internal
mammary artery; LV, left ventricular; SVG, saphenous vein graft.
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F I G U R E 1 Final successful crossing strategy in male and female patients. AWE, antegrade wire escalation; ADR, antegrade dissection and
re‐entry. [Color figure can be viewed at wileyonlinelibrary.com]

TABLE 4

3 |

Procedural complications stratified by gender

RESULTS

Variables

Male
(n = 7687)

Female
(n = 1770)

p Value

In‐hospital MACE

141 (1.8%)

51 (2.9%)

0.005

Death

35 (0.5%)

8 (0.5%)

0.985

Acute MI

43 (0.6%)

12 (0.7%)

0.554

women. The baseline clinical characteristics of the included

Repeat‐PCI

16 (0.2%)

3 (0.2%)

0.743

patients are summarized in Table 1. Compared with men, women

Stroke

6 (0.1%)

10 (0.6%)

<0.001

were older, had higher body mass index (BMI), were more likely to

Emergency CABG

5 (0.1%)

4 (0.3%)

0.048

56 (0.7%)

27 (1.5%)

0.001

364 (4.7%)

96 (5.4%)

0.225

with men. The majority of the patients in both groups were

0.672

symptomatic and presented more commonly with stable angina;

Tamponade requiring
pericardiocentesis
Perforation

Patient characteristics

During the study period, 9457 CTO PCIs were performed at the
study centers in 9457 patients, 1770 of whom (18.7%) were

have diabetes mellitus, hypertension, peripheral arterial disease,
and had higher left ventricular ejection fraction. Women were also
less likely to have had prior myocardial infarction, prior PCI and
prior coronary artery bypass graft surgery (CABG) as compared

Ellis Class 1

47 (19.7%)

29 (19.2%)

Ellis Class 2

113 (39.0%)

35 (44.9%)

Ellis Class 3

82 (28.3%)

17 (21.8%)

Ellis Class 3‐Cavity
spilling

38 (13.0%)

11 (14.1%)

Dissection/Thrombus of
Donor Artery

56 (0.7%)

14 (0.8%)

0.782

Vascular access site
complication

78 (1.0%)

27 (1.5%)

0.045

9 (0.1%)

6 (0.3%)

0.034

Contrast‐induced
nephropathy

3.1 |

however, women were more likely to present with unstable angina
(16.4% vs. 14.5%; p < 0.001) or non‐ST segment elevation myocardial infarction (NSTEMI) (10.1% vs. 7.3%; p < 0.001) compared with
men (Supporting Information: Table S1).

3.2 |

Angiographic characteristics

The angiographic characteristics of the study lesions are presented in

Abbreviations: AK, air kerma; CABG, coronary artery bypass graft surgery;
MACE, major adverse cardiac events; MI, myocardial infarction; PCI,
percutaneous coronary intervention.

Table 2. While overall, the most common CTO target vessel was the right
coronary artery (53%), the left anterior descending artery was more
frequently the target vessel in women (31.2% vs. 25.1%; p < 0.001).
Lesions in men were longer (25 [15, 40] mm vs. 23 [15, 35] mm;
p < 0.001), had larger diameter (2.9 ± 0.5 mm vs. 2.8 ± 0.5 mm; p < 0.001)
and were more likely to have unfavorable characteristics, such as proximal

clinically/angiographically significant were included in the multi-

cap ambiguity (35.7% vs. 30.7%; p < 0.001), moderate to severe proximal

variable analysis. All statistical analyses were performed using JMP,

tortuosity (30.4% vs. 25.9%; p < 0.001), a side branch at the proximal cap

version 16.0 (SAS Institute). A p < 0.05 was considered to indicate

(55.6% vs. 50.9%; p < 0.001) and blunt or stumpless proximal cap (50.1%

statistical significance.

vs. 45.4%; p < 0.001). The J‐CTO score (2.41 ± 1.28 vs. 2.20 ± 1.23;
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p < 0.001) as well as the PROGRESS‐CTO score (1.30 ± 1.02 vs.

CTO PCI in men required longer procedure time (116 [75,

1.12 ± 0.99; p < 0.001) were higher in men when compared with women.

170] min vs. 108 [71, 158] min; p < 0.001) and fluoroscopy time (43
[26, 70] min vs. 38 [23, 61] min; p < 0.001), higher Air Kerma (AK)
radiation dose (2.3 [1.4, 3.9] Gy vs. 1.5 [0.9, 2.8] Gy; p < 0.001) and

3.3

| Technical characteristics

larger contrast volume (220 [150, 300] ml vs. 200 [138, 265] ml;
p < 0.001) compared with women (Figure 3). Women had slightly

The technical characteristics of the study lesions are presented in

longer hospital stays after CTO PCI (1.53 ± 1.62 days vs. 1.44 ± 1.65

Table 3. CTO PCIs in men more often required use of antegrade

days; p = 0.045).

dissection and reentry (22.7% vs. 16.3%; p < 0.001) and the retrograde

On multivariable logistic regression using technical success as the

(31.7% vs. 26.5%; p < 0.001) approach. In women antegrade wire

outcome, age, BMI, hypertension, peripheral arterial disease, moder-

escalation was more frequently the initial crossing strategy (87.6% vs.

ate to severe calcification, moderate to severe proximal vessel

82.4%; p < 0.001) and was more successful in crossing the target lesion

tortuosity, proximal cap ambiguity, and distal cap at bifurcation were

(62.7% vs. 54.0%; p < 0.001) compared with men (Figure 1). “Interven-

associated with lower technical success, whereas female gender and

tional” collaterals were more common in women (60.3% vs. 55.9%;

the presence of interventional collaterals were associated with higher

p = 0.002) and intravascular ultrasound (IVUS) was used more

technical success (Figure 4A).

frequently in women (48.6% vs. 44.7%; p = 0.007).

Moreover, age, female gender, congestive heart failure, moderate to severe calcification, proximal cap ambiguity, and the presence
of interventional collaterals were associated with higher incidence of

3.4

| Procedural outcomes

MACE (Figure 4B).

Procedural outcomes are shown in Table 4 and Supporting Information: Table S2. The overall technical (89.2% vs. 85.6%; p < 0.001) and

4 |
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procedural (87.2% vs. 84.4%; p = 0.003) success rates were higher in
women (Figure 2, Central Illustration). The incidence of in‐hospital

The main findings of our study of CTO PCI in women versus men

MACE was 2.0% overall (192 patients) and was higher in women

are the following: (1) CTO PCI technical and procedural success

(2.9% vs. 1.8%; p = 0.005, Figure 2) as was the incidence of

were higher in women; (2) in‐hospital MACE was higher in women;

tamponade requiring pericardiocentesis (1.5% vs. 0.7%; p = 0.001)

(3) women presented more often with unstable angina or NSTEMI;

and stroke (0.6% vs. 0.1%; p < 0.001) compared with men. Overall in‐

(4) antegrade wiring was more frequently the initial as well as the

hospital mortality was low (0.5%) and similar in men and women. The

successful crossing strategy in women who underwent less

incidence of vascular access site complications (1.5% vs. 1.0%;

frequent use of more complex crossing strategies such as

p = 0.045) was higher in women, however there were no significant

retrograde and antegrade dissection and re‐entry; (5) contrast

differences in the incidence of perforation (5.4% vs 4.7%; p = 0.225)

volume, AK radiation dose, fluoroscopy time and procedure time

and dissection (0.7% vs. 0.8%; p = 0.782).

were higher in men.

F I G U R E 2 (Central Illustration). Technical success, procedural success, and MACE in male and female patients. MACE, major adverse cardiac
events. [Color figure can be viewed at wileyonlinelibrary.com]
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F I G U R E 3 Contrast volume, radiation exposure, fluoroscopy time, and procedure time in male and female patients. AK, air kerma. [Color
figure can be viewed at wileyonlinelibrary.com]

In the current cohort, women represented 19% of all patients

previous reports, women in the present study were older, perhaps

who underwent CTO PCI, which is similar with the results previously

due to the protective cardiovascular effects of estrogen until

reported from other large registries.1–4 Given the similar angiographic

menopause, and had a higher prevalence of known coronary risk

11,12

prevalence of CTOs among men and women,

this could reflect a

factors such as diabetes mellitus and hypertension.11,13,14

selection bias, potentially related to more atypical presentation of

In the present study, antegrade wiring was more frequently the

coronary artery disease in women, who are also often treated with

initial and final successful crossing strategy in women with less

medical therapy along without revascularization.12 Consistent with

frequent use of more complex crossing strategies. This is likely
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F I G U R E 4 Forest plot representing the results of the multivariable analysis on (A) technical success and (B) MACE. BMI, body mass index;
CABG, coronary artery bypass graft; CI, confidence interval; CTO, chronic total occlusion; LAD, left anterior descending artery; MACE, major
adverse cardiac events; MI, myocardial infarction; PCI, percutaneous coronary intervention; RCA, right coronary artery.

related to less complex CTO characteristics in women compared with

Pershad et al.16 recently reported a sex‐stratified analysis from

men, such as proximal cap ambiguity, moderate to severe calcifica-

the OPEN‐CTO (Outcomes, Patient Health Status, and Efficiency in

tion, and distal cap at bifurcation which is reflected in the lower

Chronic Total Occlusion Hybrid Procedures) multicenter registry,

J‐CTO and PROGRESS‐CTO score in female patients in our study.

showing that procedural success and MACE rates were similar in both

Similarly, Stahli et al.15 reported higher procedural complexity in men

sexes with an equal improvement of angina and quality of life in men

compared with women with higher use of retrograde crossing in men.

and women. Similarly, Guelker et al.,17 in a study which included 780
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patients, reported a comparable success and complication rate after

Family Fund, the Roehl Family Foundation and the Joseph Durda

CTO PCI between men and women. This may also be secondary to

Foundation. The generous gifts of these donors to the Minneapolis

biased referral patterns causing only women with lower J‐CTO and

Heart Institute Foundation's Science Center for Coronary Artery

PROGRESS‐CTO score to be referred for CTO PCI.

Disease (CCAD) helped support this study project.

In our study, technical and procedural success rates were higher

Study data were collected and managed using Research Electro-
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